Prosecution Insights
Last updated: October 02, 2026

Bioprotect Ltd.

Technology area: Medical Devices & Mechanical Engineering

2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

Bioprotect Ltd. has 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are both located within 1 distinct art unit, indicating a specific technical focus for the company's current filings. The company is working with 2 distinct examiners, so each of the 2 pending actions is being reviewed by a different official.

RODJOM, KATHERINE MARIE is the busiest examiner for the company, with 1 pending office action. This 1 action is one of the 2 total pending actions currently active. The concentration of both actions in 1 art unit, despite the involvement of 2 distinct examiners, indicates that the company's innovations are being evaluated by a single specialized group within the patent office. For practitioners, this means that while the technical standards of the art unit may be consistent, they must still account for the individual preferences of 2 different examiners. Managing these 2 pending office actions requires a strategy that addresses the specific requirements of the Medical Devices & Mechanical Engineering field as interpreted by 2 distinct reviewers. The presence of 2 examiners within a single art unit is a notable feature of this portfolio.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (50%)
1
Easy (50%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (50%)
Double-patenting only1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
RODJOM, KATHERINE MARIE 1 65.4% +34.5%
DANG, ANH TIEU 1 65.5% +35.5%

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18427167 Controlled Tissue Dissection Systems and Methods DANG, ANH TIEU 34d
18726203 MEDICAL DILATOR WITH ECHOGENETIC MARKER RODJOM, KATHERINE MARIE —

Top Art Units

Art UnitApps
3771 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18726203 MEDICAL DILATOR WITH ECHOGENETIC MARKER RODJOM, KATHERINE MARIE 3771 §103 Non-Final OA — Pending Jul 02, 2024
18427167 Controlled Tissue Dissection Systems and Methods DANG, ANH TIEU 3771 DP Final Rejection 34d Pending Jan 30, 2024

Managing Bioprotect Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month